Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,505 | 10,219 | 15,044 | 11,448 | 7,410 |
| Marketable Securities | N/A | N/A | 20,422 | 7,780 | 0 |
| Receivables | 9,885 | 6,524 | 3,523 | 1,581 | 3,970 |
| Inventories | 28,479 | 10,478 | 3,488 | 2,949 | 2,020 |
| Other current assets | 0 | 0 | 0 | 0 | 260 |
| TOTAL | $55,296 | $28,194 | $43,983 | $24,128 | $13,660 |
| Non-Current Assets | |||||
| PPE Net | 38,132 | 37,065 | 24,334 | 9,699 | 8,120 |
| Investments And Advances | 1,325 | 807 | 574 | 692 | 660 |
| Intangibles | 27,953 | 28,337 | 28,721 | 32,609 | 0 |
| Other Non-Current Assets | 10,000 | 10,000 | 0 | 0 | 39,250 |
| TOTAL | $77,410 | $76,209 | $53,629 | $43,000 | $48,030 |
| Total Assets | $132,706 | $104,403 | $97,612 | $67,128 | $61,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,068 | 861 | 232 | 144 | 470 |
| Accounts payable and accrued liabilities | 22,783 | 7,529 | 3,996 | 2,276 | 2,390 |
| Accrued Expenses | 10,872 | 10,859 | 3,575 | 1,481 | 2,700 |
| TOTAL | $42,365 | $23,248 | $7,803 | $6,326 | $7,410 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,854 | 9,105 | 6,868 | 1,345 | 1,490 |
| Other Non-Current Liabilities | 12,500 | 29,500 | 30,376 | 28,703 | 520 |
| TOTAL | $24,233 | $40,091 | $37,361 | $30,048 | $2,010 |
| Total Liabilities | $66,598 | $63,339 | $45,164 | $36,374 | $9,420 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,933 | 47,751 | N/A | N/A | N/A |
| Common Shares | 553 | 479 | 466 | 323 | 240 |
| Retained earnings | -104,549 | -90,342 | -70,302 | -45,191 | -20,230 |
| Other shareholders' equity | 0 | -158 | -673 | -1,118 | 20,530 |
| TOTAL | $66,108 | $41,064 | $52,448 | $30,754 | $52,270 |
| Total Liabilities And Equity | $132,706 | $104,403 | $97,612 | $67,128 | $61,690 |